The prevention by inhibitors of brain proptein synthesis of the hyperactivity and hyperpyrexia produced in rats by monoamine oxidase inhibition and the administration of L-tryptophan or 5-methoxy-N,N-dimethyltryptamine.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002247:Carbon Isotopes; D003513:Cycloheximide / Q000494:pharmacology; D004640:Emetine / Q000494:pharmacology; D005334:Fever / Q000139:chemically induced / Q000517:prevention & control*; D006213:Hallucinogens / Q000494:pharmacology*; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced / Q000517:prevention & control*; D008297:Male; D008738:Methyl Ethers / Q000494:pharmacology; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology; D009419:Nerve Tissue Proteins / Q000096:biosynthesis*; D011691:Puromycin / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology*; D014364:Tryptophan / Q000494:pharmacology*
D002247:Carbon Isotopes; D006213:Hallucinogens; D008738:Methyl Ethers; D009419:Nerve Tissue Proteins; D012701:Serotonin; D014191:Tranylcypromine; D011691:Puromycin; D014364:Tryptophan; D003513:Cycloheximide; D000661:Amphetamine; D004130:N,N-Dimethyltryptamine; D004640:Emetine